Literature DB >> 1716151

Enzymatic release of 5'-terminal deoxyribose phosphate residues from damaged DNA in human cells.

A Price1, T Lindahl.   

Abstract

Activities that catalyze or promote the release of 5'-terminal deoxyribose phosphate residues from DNA abasic sites previously incised by an AP endonuclease have been identified in soluble extracts of several human cell lines and calf thymus. Such excision of base-free sugar phosphate residues from apurinic/apyrimidinic sites is expected to be obligatory prior to repair by gap filling and ligation. The most efficient excision function is due to a DNA deoxyribophosphodiesterase similar to the protein found in Escherichia coli. The human enzyme has been partially purified and freed from detectable exonuclease activity. This DNA deoxyribophosphodiesterase is a Mg(2+)-requiring hydrolytic enzyme with an apparent molecular mass of approximately 47 kDa and is located in the cell nucleus. By comparison, the major nuclear 5'----3' exonuclease, DNase IV, is unable to catalyze the release of 5'-terminal deoxyribose phosphate residues as free sugar phosphates but can liberate them at a slow rate as part of small oligonucleotides. Nonenzymatic removal of 5'-terminal deoxyribose phosphate from DNA by beta-elimination promoted by polyamines and basic proteins is a very slow mechanism of release compared to enzymatic hydrolysis. We conclude that a DNA deoxyribophosphodiesterase acts at an intermediate stage between an AP endonuclease and a DNA polymerase during DNA repair at apurinic/apyrimidinc sites in mammalian cells, but several alternative routes also exist for the excision of deoxyribose phosphate residues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716151     DOI: 10.1021/bi00099a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  DNA cleavage induced by antitumor antibiotic leinamycin and its biological consequences.

Authors:  Velliyur Viswesh; Allison M Hays; Kent Gates; Daekyu Sun
Journal:  Bioorg Med Chem       Date:  2012-05-23       Impact factor: 3.641

2.  Interaction of human apurinic endonuclease and DNA polymerase beta in the base excision repair pathway.

Authors:  R A Bennett; D M Wilson; D Wong; B Demple
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  The nature of the 5'-terminus is a major determinant for DNA processing by Schizosaccharomyces pombe Rad2p, a FEN-1 family nuclease.

Authors:  J L Alleva; P W Doetsch
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

4.  Reactivity and Cross-Linking of 5'-Terminal Abasic Sites within DNA.

Authors:  Suzanne J Admiraal; Patrick J O'Brien
Journal:  Chem Res Toxicol       Date:  2017-05-22       Impact factor: 3.739

5.  Second pathway for completion of human DNA base excision-repair: reconstitution with purified proteins and requirement for DNase IV (FEN1).

Authors:  A Klungland; T Lindahl
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

6.  DNA-substrate sequence specificity of human G:T mismatch repair activity.

Authors:  R S Day
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

Review 7.  Genomic damage and its repair in young and aging brain.

Authors:  K S Rao
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

8.  Generation of single-nucleotide repair patches following excision of uracil residues from DNA.

Authors:  G Dianov; A Price; T Lindahl
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Use of oligonucleotides containing ethenoadenine to study the repair of this DNA lesion. Determination of individual and collective repair activities.

Authors:  F Oesch; C M Weiss; S Klein
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage.

Authors:  Elena Jelezcova; Ram N Trivedi; Xiao-Hong Wang; Jiang-Bo Tang; Ashley R Brown; Eva M Goellner; Sandy Schamus; Jamie L Fornsaglio; Robert W Sobol
Journal:  Mutat Res       Date:  2010-01-22       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.